News

30 September 2024: QScint awarded Phase II SBIR grant by NIH/NIBIB

30 September 2024: QScint awarded Phase II SBIR grant by NIH/NIBIB Tucson, AZ - 30 September 2024 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and beta-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant by the NIH and NIBIB to develop “Novel Isotopic Spectroscopy Imaging Tools for Advancing Targeted Alpha Cancer Therapies”.

15 July 2024: QScint Attending AAPM 2024 in Los Angeles

15 July 2024: QScint Attending AAPM 2024 in Los Angeles Tucson, AZ - 15 July 2024 - QScint Imaging Solutions LLC (QScint) will be exhibiting at the American Association of Physicists in Medicine (AAPM) annual meeting in Los Angeles July 21-24. Drop by and see us at Booth 526 to learn how to use an iQID for QA procedures on your brachytherapy seeds and sources! We’ll also be happy to show you how our iQIDs are used in cutting-edge radiopharmaceutical research.

28 June 2024: QScint Announces Commitment to Environmentally-friendly Packaging

28 June 2024: QScint announces commitment to environmentally-friendly packaging Tucson, AZ - 28 June 2024 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and positron-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced its commitment to the use of environmentally-friendly packaging for delivering systems, accessories, and spare parts. QScint President Dr. Brian Miller commented on the new initiative: “At QScint we’ve always employed re-usable containers for shipping and delivering our world-class particle imagers.

28 May 2024: QScint Installs Prototype iQID Scope

Bern, Switzerland and Tucson, AZ - 28 May 2024 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and positron-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its prototype iQID Scope window-chamber particle imager at Universitätsspital Bern. The iQID Scope is aimed to meet the emerging need for real-time, intravital microscopy of radiopharmaceuticals.

24 May 2024: QScint Installs iQID NSight Mega

24 May 2024: QScint announces installation of flagship iQID NSight Mega particle imager at Washington University in St. Louis St. Louis, MO and Tucson, AZ - May 24 2024 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and beta-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its iQID NSight Mega particle imager at Washington University in St.

29 March 2024: QScint Installs iQID NSight Mega

29 March 2024: QScint announces installation of flagship iQID Mega particle imager at Thomas Jefferson University Philadelphia, PA and Tucson, AZ - March 29, 2024 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and beta-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry announced today the installation of its iQID NSight Mega particle imager at Thomas Jefferson University. The installation expands QScint’s world-wide install base to yet another academic institution, highlighting the role of QScint’s technology in supporting fundamental research.

QScint Wins Sponsored Launch at UACI

QScint Imaging Solutions LLC was honored to win a Sponsored Launch at the University of Arizona Center for Innovation (UACI).